BioCentury
ARTICLE | Company News

Case Western Reserve University, Vision Medicines deal

December 14, 2015 8:00 AM UTC

The university granted Vision exclusive, worldwide rights to VM200, an oral small molecule that is in preclinical testing for Stargardt disease. Vision plans to start a Phase I/II trial next year. Th...